Track topics on Twitter Track topics that are important to you
(Cleveland Clinic) Cleveland Clinic researchers have identified for the first time an explanation of why patients with identical PTEN mutations often have vastly different clinical presentations. In a new study published in JAMA Network Open, a team of researchers led by Charis Eng, MD, PhD, discovered that copy number variations may act as genomic modifiers that influence the risk of autism spectrum disorder and/or developmental delay versus cancer risk in individuals with PTEN mutations.
Original Article: Cleveland clinic study clarifies genetic autism risk in PTEN patientsNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...